Skip to main content
main-content
Erschienen in: NeuroTransmitter 5/2022

16.05.2022 | Systemkrankheiten des ZNS | Zertifizierte Fortbildung

Extraartikuläre Manifestationen

Rheumatologische Erkrankungen und Neurologie: Was ist zu beachten?

verfasst von: Prof. Dr. med. Matthias Maschke

Erschienen in: NeuroTransmitter | Ausgabe 5/2022

zum CME-Kurs Einloggen, um Zugang zu erhalten

Auszug

Bei rheumatologischen Erkrankungen treten häufig extraartikuläre Manifestationen auf. Über die systemische Entzündungsreaktion führen rheumatische Erkrankungen oft zu einer Beteiligung des peripheren oder zentralen Nervensystems oder auch der Muskulatur. Daher ist es wichtig, rheumatologische Erkrankungen in die Differenzialdiagnose bei neu aufgetretenen neurologischen Erkrankungen einzubeziehen.
Literatur
1.
Zurück zum Zitat Badley EM. Rheumatic diseases: the unnoticed elephant in the room. J Rheumatol. 2008;35:6-7 Badley EM. Rheumatic diseases: the unnoticed elephant in the room. J Rheumatol. 2008;35:6-7
2.
Zurück zum Zitat Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358:903-11 Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358:903-11
3.
Zurück zum Zitat Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389:2338-48 Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389:2338-48
4.
Zurück zum Zitat McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389:2328-37 McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389:2328-37
5.
Zurück zum Zitat Salliot C, Nguyen Y, Boutron-Ruault MC, Seror R. Environment and Lifestyle: Their Influence on the Risk of RA. J Clin Med. 2020;9:3109 Salliot C, Nguyen Y, Boutron-Ruault MC, Seror R. Environment and Lifestyle: Their Influence on the Risk of RA. J Clin Med. 2020;9:3109
6.
Zurück zum Zitat Maschke M, Weiner SM. Rheumatologisch bedingte neurologische Erkrankungen. Aktuelle Neurologie. 2015;42:212-7 Maschke M, Weiner SM. Rheumatologisch bedingte neurologische Erkrankungen. Aktuelle Neurologie. 2015;42:212-7
7.
Zurück zum Zitat Westhoff G, Schneider M, Raspe H et al. Advance and unmet need of health care for patients with rheumatoid arthritis in the German population-results from the German Rheumatoid Arthritis Population Survey (GRAPS). Rheumatology. 2009;48:650-7 Westhoff G, Schneider M, Raspe H et al. Advance and unmet need of health care for patients with rheumatoid arthritis in the German population-results from the German Rheumatoid Arthritis Population Survey (GRAPS). Rheumatology. 2009;48:650-7
8.
Zurück zum Zitat McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205-19 McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205-19
9.
Zurück zum Zitat Furst DE, Emery P. Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets. Rheumatology (Oxford). 2014;53:1560-9 Furst DE, Emery P. Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets. Rheumatology (Oxford). 2014;53:1560-9
10.
Zurück zum Zitat Suwannalai P et al. Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis. Mod Rheumatol. 2012;22:15-20 Suwannalai P et al. Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis. Mod Rheumatol. 2012;22:15-20
11.
Zurück zum Zitat Reed E, Hedström AK, Hansson M et al. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity. Arthritis Res Ther. 2020;22:170 Reed E, Hedström AK, Hansson M et al. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity. Arthritis Res Ther. 2020;22:170
12.
Zurück zum Zitat Aletaha D et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569-81 Aletaha D et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569-81
13.
Zurück zum Zitat Fiehn C et al. S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs. Z Rheumatol. 2018; 77(Suppl 2):35-53 Fiehn C et al. S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs. Z Rheumatol. 2018; 77(Suppl 2):35-53
15.
Zurück zum Zitat Felson DT et al. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis. 2011;70:404-13 Felson DT et al. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis. 2011;70:404-13
16.
Zurück zum Zitat Baker KF, Isaacs JD. Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis? Ann Rheum Dis. 2018;77:175-87 Baker KF, Isaacs JD. Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis? Ann Rheum Dis. 2018;77:175-87
17.
Zurück zum Zitat Ramos-Remus C et al. Beyond the joints: neurological involvement in rheumatoid arthritis. Clin Rheumatol. 2012;31:1-12 Ramos-Remus C et al. Beyond the joints: neurological involvement in rheumatoid arthritis. Clin Rheumatol. 2012;31:1-12
18.
Zurück zum Zitat Baerwald C, Manger B, Hueber A. Depression as comorbidity of rheumatoid arthritis. Z Rheumatol. 2019;78:243-8 Baerwald C, Manger B, Hueber A. Depression as comorbidity of rheumatoid arthritis. Z Rheumatol. 2019;78:243-8
19.
Zurück zum Zitat DeQuattro K, Imboden JB. Neurologic Manifestations of Rheumatoid Arthritis. Rheum Dis Clin North Am. 2017;43:561-71 DeQuattro K, Imboden JB. Neurologic Manifestations of Rheumatoid Arthritis. Rheum Dis Clin North Am. 2017;43:561-71
20.
Zurück zum Zitat Brüggemann N, Gottschalk S, Holl-Ulrich K, Stewen J, Heide W, Seidel G. Cranial pachymeningitis: a rare neurological syndrome with heterogeneous aetiology. J Neurol Neurosurg Psychiatry. 2010;81:294-8 Brüggemann N, Gottschalk S, Holl-Ulrich K, Stewen J, Heide W, Seidel G. Cranial pachymeningitis: a rare neurological syndrome with heterogeneous aetiology. J Neurol Neurosurg Psychiatry. 2010;81:294-8
21.
Zurück zum Zitat Cianfoni A et al. Rheumatoid leptomeningitis: magnetic resonance imaging and pathologic findings - a case report. J Neuroimaging. 2010;20:192-4 Cianfoni A et al. Rheumatoid leptomeningitis: magnetic resonance imaging and pathologic findings - a case report. J Neuroimaging. 2010;20:192-4
22.
Zurück zum Zitat Manolios E, Manolios N, Spencer D. Leptomeningitis in rheumatoid arthritis. Eur J Rheumatol. 2020 Oct 8. doi: 10.5152/eurjrheum.2020.20063 Manolios E, Manolios N, Spencer D. Leptomeningitis in rheumatoid arthritis. Eur J Rheumatol. 2020 Oct 8. doi: 10.5152/eurjrheum.2020.20063
23.
Zurück zum Zitat 23 Hamed SA et al. Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis. Clin Rheumatol 2012;31:123-32 23 Hamed SA et al. Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis. Clin Rheumatol 2012;31:123-32
24.
Zurück zum Zitat Agarwal V, Singh R, Wiclaf et al. A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol. 2008;27:841-4 Agarwal V, Singh R, Wiclaf et al. A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol. 2008;27:841-4
25.
Zurück zum Zitat Weller RO, Bruckner FE, Chamberlain MA. Rheumatoid neuropathy: a histological and electrophysiological study. J Neurol Neurosurg Psychiatry. 1970;33:592-604 Weller RO, Bruckner FE, Chamberlain MA. Rheumatoid neuropathy: a histological and electrophysiological study. J Neurol Neurosurg Psychiatry. 1970;33:592-604
26.
Zurück zum Zitat Kaeley N et al. Prevalence and patterns of peripheral neuropathy in patients of rheumatoid arthritis. J Family Med Prim Care. 2019; 8:22-6 Kaeley N et al. Prevalence and patterns of peripheral neuropathy in patients of rheumatoid arthritis. J Family Med Prim Care. 2019; 8:22-6
27.
Zurück zum Zitat Ahmed Z, Powell R, Llewelyn G, Anstey A. Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF α therapy for chronic plaque psoriasis. BMJ Case Rep. 2011;pii: bcr0820114674 Ahmed Z, Powell R, Llewelyn G, Anstey A. Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF α therapy for chronic plaque psoriasis. BMJ Case Rep. 2011;pii: bcr0820114674
28.
Zurück zum Zitat Patwala K, Crump N, De Cruz P. Guillain-Barré syndrome in association with antitumour necrosis factor therapy: a case of mistaken identity. BMJ Case Rep. 2017:bcr2017219481 Patwala K, Crump N, De Cruz P. Guillain-Barré syndrome in association with antitumour necrosis factor therapy: a case of mistaken identity. BMJ Case Rep. 2017:bcr2017219481
29.
Zurück zum Zitat Naranjo A, Carmona L, Gavrila D, Balsa A, Belmonte MA, Tena X, Rodríguez-Lozano C, Sanmartí R, González-Alvaro I; EMECAR Study Group. Prevalence and associated factors of anterior atlantoaxial luxation in a nation-wide sample of rheumatoid arthritis patients. Clin Exp Rheumatol. 2004;22:427-32 Naranjo A, Carmona L, Gavrila D, Balsa A, Belmonte MA, Tena X, Rodríguez-Lozano C, Sanmartí R, González-Alvaro I; EMECAR Study Group. Prevalence and associated factors of anterior atlantoaxial luxation in a nation-wide sample of rheumatoid arthritis patients. Clin Exp Rheumatol. 2004;22:427-32
30.
Zurück zum Zitat Watson P, Fekete J, Deck J. Central nervous system vasculitis in rheumatoid arthritis. Can J Neurol Sci. 1977;4:269-72 Watson P, Fekete J, Deck J. Central nervous system vasculitis in rheumatoid arthritis. Can J Neurol Sci. 1977;4:269-72
31.
Zurück zum Zitat Neamtu L et al. Rheumatoid disease of the CNS with meningeal vasculitis presenting with a seizure. Neurology. 2001;56:814-5 Neamtu L et al. Rheumatoid disease of the CNS with meningeal vasculitis presenting with a seizure. Neurology. 2001;56:814-5
32.
Zurück zum Zitat Mariette X, Criswell LA. Primary Sjögren's Syndrome. N Engl J Med. 2018;378:931-9 Mariette X, Criswell LA. Primary Sjögren's Syndrome. N Engl J Med. 2018;378:931-9
33.
Zurück zum Zitat Vitali C et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-8 Vitali C et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-8
34.
Zurück zum Zitat Chai J, Logigian EL. Neurological manifestations of primary Sjogren's syndrome. Curr Opin Neurol. 2010;23:509-13 Chai J, Logigian EL. Neurological manifestations of primary Sjogren's syndrome. Curr Opin Neurol. 2010;23:509-13
35.
Zurück zum Zitat Goransson LG et al.Peripheral neuropathy in primary Sjogren syndrome: a population-based study. Arch Neurol. 2006;63:1612-5 Goransson LG et al.Peripheral neuropathy in primary Sjogren syndrome: a population-based study. Arch Neurol. 2006;63:1612-5
36.
Zurück zum Zitat Mori K, Iijima M, Koike H et al. The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain. 2005;128:2518-34 Mori K, Iijima M, Koike H et al. The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain. 2005;128:2518-34
37.
Zurück zum Zitat Kizawa M, Mori K, Iijima M, Koike H, Hattori N, Sobue G. Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sjögren's syndrome. J Neurol Neurosurg Psychiatry. 2006;77:967-9 Kizawa M, Mori K, Iijima M, Koike H, Hattori N, Sobue G. Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sjögren's syndrome. J Neurol Neurosurg Psychiatry. 2006;77:967-9
38.
Zurück zum Zitat Kastrup O, Maschke M, Diener HC. Pulse-cyclophosphamide in the treatment of ataxic sensory and cranial nerve neuropathy associated with Sjogren's syndrome. Clin Neurol Neurosurg. 2005;107:440-1 Kastrup O, Maschke M, Diener HC. Pulse-cyclophosphamide in the treatment of ataxic sensory and cranial nerve neuropathy associated with Sjogren's syndrome. Clin Neurol Neurosurg. 2005;107:440-1
39.
Zurück zum Zitat Ramos-Casals M, Brito-Zerón P, Bombardieri S et al. EULAR-Sjögren Syndrome Task Force Group. EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. Ann Rheum Dis 2020;79:3-18 Ramos-Casals M, Brito-Zerón P, Bombardieri S et al. EULAR-Sjögren Syndrome Task Force Group. EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. Ann Rheum Dis 2020;79:3-18
40.
Zurück zum Zitat Warnatz K, Peter HH, Schumacher M et al. Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature. Ann Rheum Dis 2003;62:50-7 Warnatz K, Peter HH, Schumacher M et al. Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature. Ann Rheum Dis 2003;62:50-7
41.
Zurück zum Zitat Kahlenberg JM, Fox DA. Advances in the medical treatment of rheumatoid arthritis. Hand Clin 2011;27:11-20 Kahlenberg JM, Fox DA. Advances in the medical treatment of rheumatoid arthritis. Hand Clin 2011;27:11-20
42.
Zurück zum Zitat Curtis JR, Patkar N, Xie A et al. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis & Rheumatism 2007;56:1125-33 Curtis JR, Patkar N, Xie A et al. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis & Rheumatism 2007;56:1125-33
43.
Zurück zum Zitat Zhang P, Li X, Li Y, Wang J, Zeng H, Zeng X. Biomed Rep. Reversible posterior leukoencephalopathy syndrome secondary to systemic-onset juvenile idiopathic arthritis: A case report and review of the literature. 2015;3:55-8 Zhang P, Li X, Li Y, Wang J, Zeng H, Zeng X. Biomed Rep. Reversible posterior leukoencephalopathy syndrome secondary to systemic-onset juvenile idiopathic arthritis: A case report and review of the literature. 2015;3:55-8
44.
Zurück zum Zitat Bharat A, Xie F, Baddley JW et al. Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases. Arthritis Care Res (Hoboken). 2012;64:612-25 Bharat A, Xie F, Baddley JW et al. Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases. Arthritis Care Res (Hoboken). 2012;64:612-25
45.
Zurück zum Zitat Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A; B S R B R Control Centre Consortium, Symmons DP; BSR Biologics Register. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis. 2010;69:522-8 Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A; B S R B R Control Centre Consortium, Symmons DP; BSR Biologics Register. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis. 2010;69:522-8
46.
Zurück zum Zitat Chan JW, Castellanos A. Infliximab and anterior optic neuropathy: case report and review of the literature. Graefes Arch Clin Exp Ophthalmol. 2010;248:283-7 Chan JW, Castellanos A. Infliximab and anterior optic neuropathy: case report and review of the literature. Graefes Arch Clin Exp Ophthalmol. 2010;248:283-7
47.
Zurück zum Zitat ten Tusscher MP, Jacobs PJ, Busch MJ et a. Bilateral anterior toxic optic neuropathy and the use of infliximab. BMJ. 2003;326:579 ten Tusscher MP, Jacobs PJ, Busch MJ et a. Bilateral anterior toxic optic neuropathy and the use of infliximab. BMJ. 2003;326:579
48.
Zurück zum Zitat von Jagow B, Kohnen T. Anterior optic neuropathy associated with adalimumab. Ophthalmologica. 2008;222:292-4 von Jagow B, Kohnen T. Anterior optic neuropathy associated with adalimumab. Ophthalmologica. 2008;222:292-4
Metadaten
Titel
Extraartikuläre Manifestationen
Rheumatologische Erkrankungen und Neurologie: Was ist zu beachten?
verfasst von
Prof. Dr. med. Matthias Maschke
Publikationsdatum
16.05.2022
Verlag
Springer Medizin
Erschienen in
NeuroTransmitter / Ausgabe 5/2022
Print ISSN: 1436-123X
Elektronische ISSN: 2196-6397
DOI
https://doi.org/10.1007/s15016-022-9432-6